Recruiting Multiple Myeloma Studies in Lincoln
About Multiple Myeloma Clinical Trials in Lincoln
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 2 multiple myeloma clinical trials recruiting participants in Lincoln, NE. These studies are seeking a combined 55 participants. Research is being sponsored by University of Nebraska. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Lincoln — FAQ
Are there multiple myeloma clinical trials in Lincoln?
Yes, there are 2 multiple myeloma clinical trials currently recruiting in Lincoln, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lincoln?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lincoln research site will contact you about next steps.
Are clinical trials in Lincoln free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lincoln studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 2 active trials in Lincoln are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated July 18, 2026 from ClinicalTrials.gov